ClinicalTrials.govpublic full text
Veliparib in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
brca1 mutation carrier, brca2 mutation carrier, ovarian epithelial tumor, recurrent fallopian tube carcinoma, recurrent ovarian carcinoma, recurrent primary peritoneal carcinoma, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 880380
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.